- Report
- February 2026
- 552 Pages
Global
From €4324EUR$4,799USD£3,708GBP
- Report
- September 2026
- 182 Pages
Global
From €3194EUR$3,545USD£2,739GBP
€3549EUR$3,939USD£3,044GBP
- Report
- September 2026
- 192 Pages
Global
From €5271EUR$5,850USD£4,520GBP
- Report
- June 2026
- 150 Pages
Global
From €2702EUR$2,999USD£2,317GBP
€3603EUR$3,999USD£3,090GBP
- Report
- July 2026
- 110 Pages
Global
From €4280EUR$4,750USD£3,670GBP
- Report
- July 2026
- 150 Pages
Global
From €4370EUR$4,850USD£3,747GBP
- Report
- January 2026
- 160 Pages
Global
From €2847EUR$3,160USD£2,442GBP
€3559EUR$3,950USD£3,052GBP
- Report
- February 2026
- 160 Pages
Global
From €2992EUR$3,320USD£2,565GBP
€3739EUR$4,150USD£3,207GBP
- Report
- February 2026
- 82 Pages
Global
From €3500EUR$4,161USD£3,106GBP
- Report
- May 2026
- 200 Pages
Global
From €3600EUR$3,995USD£3,087GBP
- Report
- August 2026
- 503 Pages
Global
From €4324EUR$4,799USD£3,708GBP
- Report
- December 2025
- 397 Pages
Global
From €4324EUR$4,799USD£3,708GBP
- Report
- September 2026
- 194 Pages
Global
From €3194EUR$3,545USD£2,739GBP
€3549EUR$3,939USD£3,044GBP
- Report
- September 2026
- 197 Pages
Global
From €3194EUR$3,545USD£2,739GBP
€3549EUR$3,939USD£3,044GBP
- Report
- September 2026
- 108 Pages
Global
From €5271EUR$5,850USD£4,520GBP
- Report
- September 2026
- 148 Pages
Global
From €5271EUR$5,850USD£4,520GBP
- Report
- September 2026
- 180 Pages
Global
From €5271EUR$5,850USD£4,520GBP
- Report
- February 2026
- 250 Pages
Global
From €4046EUR$4,490USD£3,469GBP
- Report
- January 2026
- 185 Pages
Global
From €4055EUR$4,500USD£3,477GBP
- Report
- September 2026
- 569 Pages
Global
From €5271EUR$5,850USD£4,520GBP

The Human Microbiome market is a subset of the biotechnology industry that focuses on the study of the human microbiome. The human microbiome is the collection of microorganisms that live in and on the human body, and it plays an important role in human health. The Human Microbiome market is focused on understanding the role of the microbiome in health and disease, and developing products and services to improve human health. This includes the development of diagnostics, therapeutics, and probiotics.
The Human Microbiome market is driven by advances in technology, such as next-generation sequencing, which has enabled researchers to better understand the microbiome and its role in health and disease. Additionally, the increasing prevalence of chronic diseases, such as obesity and diabetes, has increased the demand for microbiome-based products and services.
Companies in the Human Microbiome market include uBiome, Second Genome, and Seres Therapeutics. Show Less Read more